Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GlycoGenesys GLGS (formerly SafeScience SAFS) -- Ignore unavailable to you. Want to Upgrade?

To: betone who wrote (1)	12/1/2003 1:43:29 PM
From: JMarcus	Read Replies (1) \| Respond to of 56

Someone on the Yahoo thread identified GLGS as the mystery company alluded to in this article. That certainly seems plausible. The webcast mentioned glycobiology as being on MIT's "10 emerging technologies that will change the world" list. The share price and market cap sound about right for early November. GLGS is indeed based in Boston. Some of the recent price rebound is probably due to the hype of the article and speculation (or confirmation) that GLGS is the company being pumped. Marc